 | • レポートコード：MRC308GR03187 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2-3営業日） • 産業分類：化学＆材料 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の生理活性タンパク質&ペプチドの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の生理活性タンパク質&ペプチド市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 生理活性タンパク質&ペプチドの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
生理活性タンパク質&ペプチド市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・植物由来、動物由来
用途別セグメント
・食品、医薬品、化粧品、その他
主要な市場プレーヤー
・Nuritas、Gelita、Arta Peptidion、Seagarden、Phermpep、Hubei Reborn Biotech、Tus-Harvest Biotech、Zhejiang Huitai Life Health Technology、Beijing Renxinruoshui Biotech
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、生理活性タンパク質&ペプチド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な生理活性タンパク質&ペプチドメーカーの企業概要、2019年～2022年までの生理活性タンパク質&ペプチドの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な生理活性タンパク質&ペプチドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別生理活性タンパク質&ペプチドの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの生理活性タンパク質&ペプチドの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での生理活性タンパク質&ペプチド市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および生理活性タンパク質&ペプチドの産業チェーンを掲載しています。
・第14、15章では、生理活性タンパク質&ペプチドの販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 生理活性タンパク質&ペプチドの概要
– 種類別分析（2018年vs2022年vs2029年）：植物由来、動物由来
– 用途別分析（2018年vs2022年vs2029年）：食品、医薬品、化粧品、その他
– 世界の生理活性タンパク質&ペプチド市場規模・予測
– 世界の生理活性タンパク質&ペプチド生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Nuritas、Gelita、Arta Peptidion、Seagarden、Phermpep、Hubei Reborn Biotech、Tus-Harvest Biotech、Zhejiang Huitai Life Health Technology、Beijing Renxinruoshui Biotech
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：植物由来、動物由来
・用途別分析2018年-2029年：食品、医薬品、化粧品、その他
・生理活性タンパク質&ペプチドの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・生理活性タンパク質&ペプチドのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・生理活性タンパク質&ペプチドのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・生理活性タンパク質&ペプチドの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・生理活性タンパク質&ペプチドの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Bioactive Proteins and Peptides
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Bioactive Proteins and Peptides Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Plant Source
1.3.3 Animal Source
1.4 Market Analysis by Application
1.4.1 Overview: Global Bioactive Proteins and Peptides Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Food
1.4.3 Pharmaceutical
1.4.4 Cosmetic
1.4.5 Others
1.5 Global Bioactive Proteins and Peptides Market Size & Forecast
1.5.1 Global Bioactive Proteins and Peptides Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Bioactive Proteins and Peptides Sales Quantity (2018-2029)
1.5.3 Global Bioactive Proteins and Peptides Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Nuritas
2.1.1 Nuritas Details
2.1.2 Nuritas Major Business
2.1.3 Nuritas Bioactive Proteins and Peptides Product and Services
2.1.4 Nuritas Bioactive Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Nuritas Recent Developments/Updates
2.2 Gelita
2.2.1 Gelita Details
2.2.2 Gelita Major Business
2.2.3 Gelita Bioactive Proteins and Peptides Product and Services
2.2.4 Gelita Bioactive Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gelita Recent Developments/Updates
2.3 Arta Peptidion
2.3.1 Arta Peptidion Details
2.3.2 Arta Peptidion Major Business
2.3.3 Arta Peptidion Bioactive Proteins and Peptides Product and Services
2.3.4 Arta Peptidion Bioactive Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Arta Peptidion Recent Developments/Updates
2.4 Seagarden
2.4.1 Seagarden Details
2.4.2 Seagarden Major Business
2.4.3 Seagarden Bioactive Proteins and Peptides Product and Services
2.4.4 Seagarden Bioactive Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Seagarden Recent Developments/Updates
2.5 Phermpep
2.5.1 Phermpep Details
2.5.2 Phermpep Major Business
2.5.3 Phermpep Bioactive Proteins and Peptides Product and Services
2.5.4 Phermpep Bioactive Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Phermpep Recent Developments/Updates
2.6 Hubei Reborn Biotech
2.6.1 Hubei Reborn Biotech Details
2.6.2 Hubei Reborn Biotech Major Business
2.6.3 Hubei Reborn Biotech Bioactive Proteins and Peptides Product and Services
2.6.4 Hubei Reborn Biotech Bioactive Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hubei Reborn Biotech Recent Developments/Updates
2.7 Tus-Harvest Biotech
2.7.1 Tus-Harvest Biotech Details
2.7.2 Tus-Harvest Biotech Major Business
2.7.3 Tus-Harvest Biotech Bioactive Proteins and Peptides Product and Services
2.7.4 Tus-Harvest Biotech Bioactive Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Tus-Harvest Biotech Recent Developments/Updates
2.8 Zhejiang Huitai Life Health Technology
2.8.1 Zhejiang Huitai Life Health Technology Details
2.8.2 Zhejiang Huitai Life Health Technology Major Business
2.8.3 Zhejiang Huitai Life Health Technology Bioactive Proteins and Peptides Product and Services
2.8.4 Zhejiang Huitai Life Health Technology Bioactive Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Zhejiang Huitai Life Health Technology Recent Developments/Updates
2.9 Beijing Renxinruoshui Biotech
2.9.1 Beijing Renxinruoshui Biotech Details
2.9.2 Beijing Renxinruoshui Biotech Major Business
2.9.3 Beijing Renxinruoshui Biotech Bioactive Proteins and Peptides Product and Services
2.9.4 Beijing Renxinruoshui Biotech Bioactive Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Beijing Renxinruoshui Biotech Recent Developments/Updates
3 Competitive Environment: Bioactive Proteins and Peptides by Manufacturer
3.1 Global Bioactive Proteins and Peptides Sales Quantity by Manufacturer (2018-2023)
3.2 Global Bioactive Proteins and Peptides Revenue by Manufacturer (2018-2023)
3.3 Global Bioactive Proteins and Peptides Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Bioactive Proteins and Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Bioactive Proteins and Peptides Manufacturer Market Share in 2022
3.4.2 Top 6 Bioactive Proteins and Peptides Manufacturer Market Share in 2022
3.5 Bioactive Proteins and Peptides Market: Overall Company Footprint Analysis
3.5.1 Bioactive Proteins and Peptides Market: Region Footprint
3.5.2 Bioactive Proteins and Peptides Market: Company Product Type Footprint
3.5.3 Bioactive Proteins and Peptides Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Bioactive Proteins and Peptides Market Size by Region
4.1.1 Global Bioactive Proteins and Peptides Sales Quantity by Region (2018-2029)
4.1.2 Global Bioactive Proteins and Peptides Consumption Value by Region (2018-2029)
4.1.3 Global Bioactive Proteins and Peptides Average Price by Region (2018-2029)
4.2 North America Bioactive Proteins and Peptides Consumption Value (2018-2029)
4.3 Europe Bioactive Proteins and Peptides Consumption Value (2018-2029)
4.4 Asia-Pacific Bioactive Proteins and Peptides Consumption Value (2018-2029)
4.5 South America Bioactive Proteins and Peptides Consumption Value (2018-2029)
4.6 Middle East and Africa Bioactive Proteins and Peptides Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Bioactive Proteins and Peptides Sales Quantity by Type (2018-2029)
5.2 Global Bioactive Proteins and Peptides Consumption Value by Type (2018-2029)
5.3 Global Bioactive Proteins and Peptides Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Bioactive Proteins and Peptides Sales Quantity by Application (2018-2029)
6.2 Global Bioactive Proteins and Peptides Consumption Value by Application (2018-2029)
6.3 Global Bioactive Proteins and Peptides Average Price by Application (2018-2029)
7 North America
7.1 North America Bioactive Proteins and Peptides Sales Quantity by Type (2018-2029)
7.2 North America Bioactive Proteins and Peptides Sales Quantity by Application (2018-2029)
7.3 North America Bioactive Proteins and Peptides Market Size by Country
7.3.1 North America Bioactive Proteins and Peptides Sales Quantity by Country (2018-2029)
7.3.2 North America Bioactive Proteins and Peptides Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Bioactive Proteins and Peptides Sales Quantity by Type (2018-2029)
8.2 Europe Bioactive Proteins and Peptides Sales Quantity by Application (2018-2029)
8.3 Europe Bioactive Proteins and Peptides Market Size by Country
8.3.1 Europe Bioactive Proteins and Peptides Sales Quantity by Country (2018-2029)
8.3.2 Europe Bioactive Proteins and Peptides Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Bioactive Proteins and Peptides Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Bioactive Proteins and Peptides Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Bioactive Proteins and Peptides Market Size by Region
9.3.1 Asia-Pacific Bioactive Proteins and Peptides Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Bioactive Proteins and Peptides Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Bioactive Proteins and Peptides Sales Quantity by Type (2018-2029)
10.2 South America Bioactive Proteins and Peptides Sales Quantity by Application (2018-2029)
10.3 South America Bioactive Proteins and Peptides Market Size by Country
10.3.1 South America Bioactive Proteins and Peptides Sales Quantity by Country (2018-2029)
10.3.2 South America Bioactive Proteins and Peptides Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Bioactive Proteins and Peptides Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Bioactive Proteins and Peptides Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Bioactive Proteins and Peptides Market Size by Country
11.3.1 Middle East & Africa Bioactive Proteins and Peptides Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Bioactive Proteins and Peptides Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Bioactive Proteins and Peptides Market Drivers
12.2 Bioactive Proteins and Peptides Market Restraints
12.3 Bioactive Proteins and Peptides Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Bioactive Proteins and Peptides and Key Manufacturers
13.2 Manufacturing Costs Percentage of Bioactive Proteins and Peptides
13.3 Bioactive Proteins and Peptides Production Process
13.4 Bioactive Proteins and Peptides Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Bioactive Proteins and Peptides Typical Distributors
14.3 Bioactive Proteins and Peptides Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Bioactive Proteins and Peptides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Bioactive Proteins and Peptides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Nuritas Basic Information, Manufacturing Base and Competitors
Table 4. Nuritas Major Business
Table 5. Nuritas Bioactive Proteins and Peptides Product and Services
Table 6. Nuritas Bioactive Proteins and Peptides Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Nuritas Recent Developments/Updates
Table 8. Gelita Basic Information, Manufacturing Base and Competitors
Table 9. Gelita Major Business
Table 10. Gelita Bioactive Proteins and Peptides Product and Services
Table 11. Gelita Bioactive Proteins and Peptides Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Gelita Recent Developments/Updates
Table 13. Arta Peptidion Basic Information, Manufacturing Base and Competitors
Table 14. Arta Peptidion Major Business
Table 15. Arta Peptidion Bioactive Proteins and Peptides Product and Services
Table 16. Arta Peptidion Bioactive Proteins and Peptides Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Arta Peptidion Recent Developments/Updates
Table 18. Seagarden Basic Information, Manufacturing Base and Competitors
Table 19. Seagarden Major Business
Table 20. Seagarden Bioactive Proteins and Peptides Product and Services
Table 21. Seagarden Bioactive Proteins and Peptides Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Seagarden Recent Developments/Updates
Table 23. Phermpep Basic Information, Manufacturing Base and Competitors
Table 24. Phermpep Major Business
Table 25. Phermpep Bioactive Proteins and Peptides Product and Services
Table 26. Phermpep Bioactive Proteins and Peptides Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Phermpep Recent Developments/Updates
Table 28. Hubei Reborn Biotech Basic Information, Manufacturing Base and Competitors
Table 29. Hubei Reborn Biotech Major Business
Table 30. Hubei Reborn Biotech Bioactive Proteins and Peptides Product and Services
Table 31. Hubei Reborn Biotech Bioactive Proteins and Peptides Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hubei Reborn Biotech Recent Developments/Updates
Table 33. Tus-Harvest Biotech Basic Information, Manufacturing Base and Competitors
Table 34. Tus-Harvest Biotech Major Business
Table 35. Tus-Harvest Biotech Bioactive Proteins and Peptides Product and Services
Table 36. Tus-Harvest Biotech Bioactive Proteins and Peptides Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Tus-Harvest Biotech Recent Developments/Updates
Table 38. Zhejiang Huitai Life Health Technology Basic Information, Manufacturing Base and Competitors
Table 39. Zhejiang Huitai Life Health Technology Major Business
Table 40. Zhejiang Huitai Life Health Technology Bioactive Proteins and Peptides Product and Services
Table 41. Zhejiang Huitai Life Health Technology Bioactive Proteins and Peptides Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Zhejiang Huitai Life Health Technology Recent Developments/Updates
Table 43. Beijing Renxinruoshui Biotech Basic Information, Manufacturing Base and Competitors
Table 44. Beijing Renxinruoshui Biotech Major Business
Table 45. Beijing Renxinruoshui Biotech Bioactive Proteins and Peptides Product and Services
Table 46. Beijing Renxinruoshui Biotech Bioactive Proteins and Peptides Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Beijing Renxinruoshui Biotech Recent Developments/Updates
Table 48. Global Bioactive Proteins and Peptides Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 49. Global Bioactive Proteins and Peptides Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Bioactive Proteins and Peptides Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 51. Market Position of Manufacturers in Bioactive Proteins and Peptides, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Bioactive Proteins and Peptides Production Site of Key Manufacturer
Table 53. Bioactive Proteins and Peptides Market: Company Product Type Footprint
Table 54. Bioactive Proteins and Peptides Market: Company Product Application Footprint
Table 55. Bioactive Proteins and Peptides New Market Entrants and Barriers to Market Entry
Table 56. Bioactive Proteins and Peptides Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Bioactive Proteins and Peptides Sales Quantity by Region (2018-2023) & (Tons)
Table 58. Global Bioactive Proteins and Peptides Sales Quantity by Region (2024-2029) & (Tons)
Table 59. Global Bioactive Proteins and Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Bioactive Proteins and Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Bioactive Proteins and Peptides Average Price by Region (2018-2023) & (US$/Ton)
Table 62. Global Bioactive Proteins and Peptides Average Price by Region (2024-2029) & (US$/Ton)
Table 63. Global Bioactive Proteins and Peptides Sales Quantity by Type (2018-2023) & (Tons)
Table 64. Global Bioactive Proteins and Peptides Sales Quantity by Type (2024-2029) & (Tons)
Table 65. Global Bioactive Proteins and Peptides Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Bioactive Proteins and Peptides Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Bioactive Proteins and Peptides Average Price by Type (2018-2023) & (US$/Ton)
Table 68. Global Bioactive Proteins and Peptides Average Price by Type (2024-2029) & (US$/Ton)
Table 69. Global Bioactive Proteins and Peptides Sales Quantity by Application (2018-2023) & (Tons)
Table 70. Global Bioactive Proteins and Peptides Sales Quantity by Application (2024-2029) & (Tons)
Table 71. Global Bioactive Proteins and Peptides Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Bioactive Proteins and Peptides Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Bioactive Proteins and Peptides Average Price by Application (2018-2023) & (US$/Ton)
Table 74. Global Bioactive Proteins and Peptides Average Price by Application (2024-2029) & (US$/Ton)
Table 75. North America Bioactive Proteins and Peptides Sales Quantity by Type (2018-2023) & (Tons)
Table 76. North America Bioactive Proteins and Peptides Sales Quantity by Type (2024-2029) & (Tons)
Table 77. North America Bioactive Proteins and Peptides Sales Quantity by Application (2018-2023) & (Tons)
Table 78. North America Bioactive Proteins and Peptides Sales Quantity by Application (2024-2029) & (Tons)
Table 79. North America Bioactive Proteins and Peptides Sales Quantity by Country (2018-2023) & (Tons)
Table 80. North America Bioactive Proteins and Peptides Sales Quantity by Country (2024-2029) & (Tons)
Table 81. North America Bioactive Proteins and Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Bioactive Proteins and Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Bioactive Proteins and Peptides Sales Quantity by Type (2018-2023) & (Tons)
Table 84. Europe Bioactive Proteins and Peptides Sales Quantity by Type (2024-2029) & (Tons)
Table 85. Europe Bioactive Proteins and Peptides Sales Quantity by Application (2018-2023) & (Tons)
Table 86. Europe Bioactive Proteins and Peptides Sales Quantity by Application (2024-2029) & (Tons)
Table 87. Europe Bioactive Proteins and Peptides Sales Quantity by Country (2018-2023) & (Tons)
Table 88. Europe Bioactive Proteins and Peptides Sales Quantity by Country (2024-2029) & (Tons)
Table 89. Europe Bioactive Proteins and Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Bioactive Proteins and Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Bioactive Proteins and Peptides Sales Quantity by Type (2018-2023) & (Tons)
Table 92. Asia-Pacific Bioactive Proteins and Peptides Sales Quantity by Type (2024-2029) & (Tons)
Table 93. Asia-Pacific Bioactive Proteins and Peptides Sales Quantity by Application (2018-2023) & (Tons)
Table 94. Asia-Pacific Bioactive Proteins and Peptides Sales Quantity by Application (2024-2029) & (Tons)
Table 95. Asia-Pacific Bioactive Proteins and Peptides Sales Quantity by Region (2018-2023) & (Tons)
Table 96. Asia-Pacific Bioactive Proteins and Peptides Sales Quantity by Region (2024-2029) & (Tons)
Table 97. Asia-Pacific Bioactive Proteins and Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Bioactive Proteins and Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Bioactive Proteins and Peptides Sales Quantity by Type (2018-2023) & (Tons)
Table 100. South America Bioactive Proteins and Peptides Sales Quantity by Type (2024-2029) & (Tons)
Table 101. South America Bioactive Proteins and Peptides Sales Quantity by Application (2018-2023) & (Tons)
Table 102. South America Bioactive Proteins and Peptides Sales Quantity by Application (2024-2029) & (Tons)
Table 103. South America Bioactive Proteins and Peptides Sales Quantity by Country (2018-2023) & (Tons)
Table 104. South America Bioactive Proteins and Peptides Sales Quantity by Country (2024-2029) & (Tons)
Table 105. South America Bioactive Proteins and Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Bioactive Proteins and Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Bioactive Proteins and Peptides Sales Quantity by Type (2018-2023) & (Tons)
Table 108. Middle East & Africa Bioactive Proteins and Peptides Sales Quantity by Type (2024-2029) & (Tons)
Table 109. Middle East & Africa Bioactive Proteins and Peptides Sales Quantity by Application (2018-2023) & (Tons)
Table 110. Middle East & Africa Bioactive Proteins and Peptides Sales Quantity by Application (2024-2029) & (Tons)
Table 111. Middle East & Africa Bioactive Proteins and Peptides Sales Quantity by Region (2018-2023) & (Tons)
Table 112. Middle East & Africa Bioactive Proteins and Peptides Sales Quantity by Region (2024-2029) & (Tons)
Table 113. Middle East & Africa Bioactive Proteins and Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Bioactive Proteins and Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Bioactive Proteins and Peptides Raw Material
Table 116. Key Manufacturers of Bioactive Proteins and Peptides Raw Materials
Table 117. Bioactive Proteins and Peptides Typical Distributors
Table 118. Bioactive Proteins and Peptides Typical Customers
List of Figures
Figure 1. Bioactive Proteins and Peptides Picture
Figure 2. Global Bioactive Proteins and Peptides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Bioactive Proteins and Peptides Consumption Value Market Share by Type in 2022
Figure 4. Plant Source Examples
Figure 5. Animal Source Examples
Figure 6. Global Bioactive Proteins and Peptides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Bioactive Proteins and Peptides Consumption Value Market Share by Application in 2022
Figure 8. Food Examples
Figure 9. Pharmaceutical Examples
Figure 10. Cosmetic Examples
Figure 11. Others Examples
Figure 12. Global Bioactive Proteins and Peptides Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Bioactive Proteins and Peptides Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Bioactive Proteins and Peptides Sales Quantity (2018-2029) & (Tons)
Figure 15. Global Bioactive Proteins and Peptides Average Price (2018-2029) & (US$/Ton)
Figure 16. Global Bioactive Proteins and Peptides Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Bioactive Proteins and Peptides Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Bioactive Proteins and Peptides by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Bioactive Proteins and Peptides Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Bioactive Proteins and Peptides Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Bioactive Proteins and Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Bioactive Proteins and Peptides Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Bioactive Proteins and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Bioactive Proteins and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Bioactive Proteins and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Bioactive Proteins and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Bioactive Proteins and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Bioactive Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Bioactive Proteins and Peptides Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Bioactive Proteins and Peptides Average Price by Type (2018-2029) & (US$/Ton)
Figure 31. Global Bioactive Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Bioactive Proteins and Peptides Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Bioactive Proteins and Peptides Average Price by Application (2018-2029) & (US$/Ton)
Figure 34. North America Bioactive Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Bioactive Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Bioactive Proteins and Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Bioactive Proteins and Peptides Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Bioactive Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Bioactive Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Bioactive Proteins and Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Bioactive Proteins and Peptides Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Bioactive Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Bioactive Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Bioactive Proteins and Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Bioactive Proteins and Peptides Consumption Value Market Share by Region (2018-2029)
Figure 54. China Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Bioactive Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Bioactive Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Bioactive Proteins and Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Bioactive Proteins and Peptides Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Bioactive Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Bioactive Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Bioactive Proteins and Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Bioactive Proteins and Peptides Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Bioactive Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Bioactive Proteins and Peptides Market Drivers
Figure 75. Bioactive Proteins and Peptides Market Restraints
Figure 76. Bioactive Proteins and Peptides Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Bioactive Proteins and Peptides in 2022
Figure 79. Manufacturing Process Analysis of Bioactive Proteins and Peptides
Figure 80. Bioactive Proteins and Peptides Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source